Consumer products company Colgate-Palmolive (NYSE: CL) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 1% year on year to $5.11 billion. Its non-GAAP profit of $0.92 per share was 2.8% above analysts’ consensus estimates.

Is now the time to buy CL? Find out in our full research report (it’s free).

StockStory’s Take

Colgate-Palmolive’s second quarter results were characterized by modest year-on-year growth, as the company navigated a challenging operating environment marked by persistent raw material inflation and category volatility. Management attributed the quarter’s performance to improved revenue growth management, resilient performance in core brands, and innovation across product categories. CEO Noel Wallace highlighted the importance of “broad-based strength across geographies, categories and price tiers,” while acknowledging the impact of cautious consumer behavior, particularly in North America and certain international markets. The company also pointed to ongoing investments in product innovation and digital capabilities as central to sustaining competitiveness.

Looking forward, Colgate-Palmolive’s strategy is anchored in advancing its 2030 plan, with a focus on productivity initiatives, omnichannel execution, and a balanced approach to pricing and value. Management believes these efforts will help offset headwinds from ongoing cost inflation and fluctuating consumer demand. CEO Noel Wallace emphasized the company’s intent to “continue to invest back behind the business,” including accelerating innovation, leveraging AI and data analytics, and optimizing the supply chain. While management remains cautiously optimistic about category recovery in the second half of the year, it underscored the need for continued agility given the uncertain macroeconomic outlook.

Key Insights from Management’s Remarks

Management pointed to targeted innovation, investment in digital capabilities, and a new productivity initiative as major drivers of both recent performance and the strategic outlook.

• Core brand innovation: The company rolled out new and reformulated products, including the global relaunch of Colgate Total and premium offerings like Miracle Repair serum, aiming to drive incremental category growth and premiumization across diverse markets.

• Productivity initiative launched: Colgate-Palmolive introduced a three-year productivity program, with $200 million to $300 million in planned charges, focused on capability building, innovation, and accelerating the transition to its 2030 strategy. CFO Stan Sutula indicated savings would mirror past initiatives and support reinvestment.

• Revenue growth management (RGM): Management emphasized the use of price pack architecture, larger multipacks, and smaller size offerings to appeal to cost-sensitive consumers, particularly in emerging markets. These tactics are designed to balance value and pricing power.

• Hill’s Pet Nutrition strength: The Hill’s brand continued to outperform, delivering mid-single-digit organic growth even in a flat pet food category. Growth was attributed to therapeutic product innovation, professional advocacy, and a withdrawal from private label manufacturing.

• Geographic divergence: While Latin America showed incremental share gains from innovation, the region, along with parts of Europe and Asia, experienced consumer caution and volatility. Management noted that food inflation in Brazil and urban softness in India led to careful price and product adjustments.

Drivers of Future Performance

Colgate-Palmolive expects near-term performance to be shaped by continued cost inflation, category trends, and disciplined investment in innovation and omnichannel capabilities.

• Cost and margin management: Ongoing raw material and packaging cost pressures, especially in fats and oils, are expected to challenge margins. The company’s productivity initiative aims to deliver incremental savings that can be reinvested in growth or used to stabilize profitability, with gross margin guidance roughly flat for the year.

• Category and market recovery: Management anticipates only modest improvement in consumer categories during the second half of the year, with regional differences. U.S. and European markets remain cautious, while incremental pricing and innovation are expected to support growth in Latin America and Asia, subject to consumer sentiment and macroeconomic factors.

• Innovation and digital investment: The 2030 strategy prioritizes expanded innovation, adoption of AI and data analytics in revenue management, and harmonizing omnichannel demand generation. These initiatives are intended to drive household penetration and brand health, supporting long-term organic sales growth and consistent earnings per share expansion.

Catalysts in Upcoming Quarters

In the upcoming quarters, the StockStory team will closely monitor (1) the execution and realized savings from the new productivity initiative, (2) the effectiveness of recent product and brand relaunches, especially Colgate Total and Hill’s, in driving market share, and (3) the company’s ability to manage input cost inflation while maintaining or improving margins. Progress in digital transformation and omnichannel execution will also be key markers of strategic success.

Colgate-Palmolive currently trades at $85, up from $83.89 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).

High Quality Stocks for All Market Conditions

Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.

Take advantage of the rebound by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.